ArticleMolecules (Basel, Switzerland)2026
Inclusion Complexes Between α-Cyclodextrins and Xenon: Molecular Dynamics Simulations and Experimental Study.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xenon (Xe) is an inert noble gas receiving increasing attention in medical research due to its anesthetic properties, ability to regulate metabolic processes, and broad organoprotective effects. Due to its small size and non-covalent intermolecular interactions, Xe can be encapsulated within α-cyclodextrin (α-CD). In this study, we combine a theoretical study based on molecular mechanics (MM) and molecular dynamics (MD) simulations with the synthesis and characterization of the α-CD/Xe inclusion complex. During the MD simulations, surface interactions and the formation of inclusion complexes, with Xe atoms encapsulated within the α-CD cavity, were observed in aqueous solution. As the Xe concentration in water increased, α-CD/Xe inclusion complexes with 1:1, 1:2, and 1:3 stoichiometries were formed and remained stable over time, suggesting increasingly effective encapsulation at higher pressures. Following this computational investigation, experimental work was conducted to synthesize and characterize the α-CD/Xe inclusion complex using a liquid-phase encapsulation method. The complexes were prepared at Xe loading pressures of 2, 4, 6, and 8 bar. Thermogravimetric analysis (TGA) revealed weight loss between 100 and 200 °C. The effective encapsulation of Xe was also confirmed by solid-phase microextraction coupled with gas chromatography-mass spectrometry (SPME-GC-MS), which detected the characteristic m/z signals of Xe and allowed monitoring of its release over time upon contact with aqueous solution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.